Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rapid Biosensor Systems to launch breathalyzer test

This article was originally published in The Gray Sheet

Executive Summary

Rapid Biosensor Systems is planning an initial March debut of its TB Breathalyzer, a light-weight, portable, non-invasive screening device for early-stage tuberculosis. While initial launches will be in India and South Africa, the Cambridge, England, company says it will simultaneously begin the approval processes with FDA and Great Britain's Medicines and Healthcare Products Regulatory Agency. The breathalyzer delivers a positive or negative result with 95% accuracy within minutes, as opposed to the most prevalent test for TB in use, the Mantoux TB test, which involves a 72-hour wait time, according to the company
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel